Biofarma 1 Maj -

: The organization is actively involved in clinical trials, such as the development of the RV3-BB rotavirus vaccine Biofarma Group (CDMO) Separate from the Indonesian entity is the Biofarma Group

As a responsible corporate citizen, Biofarma 1 Maj is committed to sustainability and social responsibility. The company recognizes the impact of its operations on the environment and strives to minimize its ecological footprint. Through various initiatives and programs, Biofarma 1 Maj promotes environmentally friendly practices, supports local communities, and advocates for access to healthcare and education. biofarma 1 maj